Literature DB >> 7489948

Is day case liver biopsy underutilised?

A C Douds1, A E Joseph, C Finlayson, J D Maxwell.   

Abstract

Day case liver biopsies are rarely performed nationally but have been routine practice in selected patients in our hospital since 1989. We have audited our experience of this procedure to compare its safety, and efficacy with inpatient biopsy and assess patient acceptability. Audit data were collected retrospectively on liver biopsies performed at a teaching hospital over 42 months. Acceptability of day case biopsy was assessed by a questionnaire. A total of 182 of 546 biopsies were day cases (33%). The specimen quality was similar in both groups. The overall complication rate did not significantly differ between the two groups (2.7% day case v 3.3% inpatients). There were no deaths or episodes of haemorrhage in the day cases but one patient developed a pneumothorax. Some 91% of those who had a day case biopsy were satisfied with the procedure. Day case liver biopsy is safe, effective, and acceptable in selected patients.

Entities:  

Mesh:

Year:  1995        PMID: 7489948      PMCID: PMC1382913          DOI: 10.1136/gut.37.4.574

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  Hemobilia secondary to percutaneous liver biopsy.

Authors:  J D Levinson; G Olsen; J W Terman; C R Cleaveland; C P Graham; K J Breen
Journal:  Arch Intern Med       Date:  1972-09

2.  Outpatient liver biopsy: how safe is it?

Authors:  G Garcia-Tsao; J L Boyer
Journal:  Ann Intern Med       Date:  1993-01-15       Impact factor: 25.391

3.  Liver biopsy as a day-case procedure: selection and complications in 200 consecutive patients.

Authors:  D Westaby; B R MacDougall; R Williams
Journal:  Br Med J       Date:  1980-11-15

4.  Percutaneous biopsy of the liver as a procedure for outpatients.

Authors:  C M Knauer
Journal:  Gastroenterology       Date:  1978-01       Impact factor: 22.682

5.  Outpatient liver biopsy: one man's experience.

Authors:  R A Wright
Journal:  South Med J       Date:  1991-07       Impact factor: 0.954

6.  Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London.

Authors:  I T Gilmore; A Burroughs; I M Murray-Lyon; R Williams; D Jenkins; A Hopkins
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

7.  Statement on outpatient percutaneous liver biopsy.

Authors:  W H Jacobs; S B Goldberg
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

8.  Outcome of patients hospitalized for complications after outpatient liver biopsy.

Authors:  C H Janes; K D Lindor
Journal:  Ann Intern Med       Date:  1993-01-15       Impact factor: 25.391

9.  Liver biopsy: complications in 1000 inpatients and outpatients.

Authors:  J Perrault; D B McGill; B J Ott; W F Taylor
Journal:  Gastroenterology       Date:  1978-01       Impact factor: 22.682

  9 in total
  10 in total

1.  Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology.

Authors:  A Grant; J Neuberger
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

Review 2.  Liver biopsy: when, how, by whom, and where?

Authors:  D B McGill
Journal:  Curr Gastroenterol Rep       Date:  2001-02

3.  Outpatient liver biopsy: a prospective evaluation of 500 cases.

Authors:  P Beddy; I L Lyburn; T Geoghegan; O Buckley; A R Buckley; W C Torreggiani
Journal:  Gut       Date:  2006-10-06       Impact factor: 23.059

Review 4.  Feasibility and experience of nurse-led ultrasound-guided percutaneous liver biopsy.

Authors:  Elizabeth Anne Farrington; Giles Maskell; Hyder Syed Hussaini
Journal:  Frontline Gastroenterol       Date:  2012-04-13

5.  Liver biopsy for parenchymal liver disease - is routine real time image guidance unnecessary?

Authors:  Anil John; Saad Al Kaabi; Madiha Emran Soofi; Muneera Mohannadi; Salva Manam Kandath; Moataz Derbala; Rafie Yakoub; Esra Mohammed Al-Ahdal; Manik Sharma; Hamid Wani; Nazeeh Dweik; Anjum John; Mohammed Tariq Butt
Journal:  Indian J Gastroenterol       Date:  2013-09-19

Review 6.  Why, who and how should perform liver biopsy in chronic liver diseases.

Authors:  Ioan Sporea; Alina Popescu; Roxana Sirli
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

7.  Outpatient blind percutaneous liver biopsy in infants and children: is it safe?

Authors:  Mortada H El-Shabrawi; Hanaa M El-Karaksy; Sawsan H Okahsa; Naglaa M Kamal; Gamal El-Batran; Khaled A Badr
Journal:  Saudi J Gastroenterol       Date:  2012 Jan-Feb       Impact factor: 2.485

Review 8.  Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis.

Authors:  Wenwen Jin; Zhonghua Lin; Yongning Xin; Xiangjun Jiang; Quanjiang Dong; Shiying Xuan
Journal:  BMC Gastroenterol       Date:  2012-02-14       Impact factor: 3.067

9.  Non-invasive histologic markers of liver disease in patients with chronic hepatitis B.

Authors:  Simin Dokht Shoaei; Shahnaz Sali; Mehdi Karamipour; Esmail Riahi
Journal:  Hepat Mon       Date:  2014-02-28       Impact factor: 0.660

10.  Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology.

Authors:  James Neuberger; Jai Patel; Helen Caldwell; Susan Davies; Vanessa Hebditch; Coral Hollywood; Stefan Hubscher; Salil Karkhanis; Will Lester; Nicholas Roslund; Rebecca West; Judith I Wyatt; Mathis Heydtmann
Journal:  Gut       Date:  2020-05-28       Impact factor: 23.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.